|Noninvasive Cardiac Screening in Young Athletes With Ventricular Arrhythmias.|
|Jump to Full Text|
|PMID: 23219000 Owner: NLM Status: Publisher|
|The aim of this study was to analyze using noninvasive cardiac examinations a series of young athletes discovered to have ventricular arrhythmias (VAs) during the preparticipation screening program for competitive sports. One hundred forty-five athletes (mean age 17 ± 5 years) were evaluated. The study protocol included electrocardiography (ECG), exercise testing, 2-dimensional and Doppler echocardiography, 24-hour Holter monitoring, signal-averaged ECG, and in selected cases contrast-enhanced cardiac magnetic resonance imaging. Results of ECG were normal in most athletes (85%). VAs were initially detected prevalently during exercise testing (85%) and in the remaining cases on ECG and Holter monitoring. Premature ventricular complexes disappeared during exercise in 56% of subjects. Premature ventricular complexes during Holter monitoring averaged 4,700 per day, predominantly monomorphic (88%), single, and/or in couplets (79%). The most important echocardiographic findings were mitral valve prolapse in 29 patients (20%), congenital heart disease in 4 (3%), and right ventricular regional kinetic abnormalities in 5 (3.5%). On cardiac magnetic resonance imaging, right ventricular regional kinetic abnormalities were detected in 9 of 30 athletes and were diagnostic of arrhythmogenic right ventricular cardiomyopathy in only 1 athlete. Overall, 30% of athletes were judged to have potentially dangerous VAs. In asymptomatic athletes with prevalently normal ECG, most VAs can be identified by adding an exercise test during preparticipation screening. In conclusion, cardiac screening with noninvasive examinations remains a fundamental tool for the identification of a possible pathologic substrate and for the characterization of electrical instability.|
|Alexandros Klavdios Steriotis; Andrea Nava; Ilaria Rigato; Elisa Mazzotti; Luciano Daliento; Gaetano Thiene; Cristina Basso; Domenico Corrado; Barbara Bauce|
|Type: JOURNAL ARTICLE Date: 2012-12-6|
|Title: The American journal of cardiology Volume: - ISSN: 1879-1913 ISO Abbreviation: Am. J. Cardiol. Publication Date: 2012 Dec|
|Created Date: 2012-12-10 Completed Date: - Revised Date: -|
Medline Journal Info:
|Nlm Unique ID: 0207277 Medline TA: Am J Cardiol Country: -|
|Languages: ENG Pagination: - Citation Subset: -|
|Copyright © 2013 Elsevier Inc. All rights reserved.|
|Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Padua, Italy. Electronic address: firstname.lastname@example.org.|
|APA/MLA Format Download EndNote Download BibTex|
Journal ID (nlm-ta): Am J Cardiol
Journal ID (iso-abbrev): Am. J. Cardiol
Publisher: Excerpta Medica
© 2013 Elsevier Inc.
Received Day: 26 Month: 9 Year: 2012
Revision Received Day: 17 Month: 10 Year: 2012
Accepted Day: 17 Month: 10 Year: 2012
pmc-release publication date: Day: 15 Month: 2 Year: 2013
Print publication date: Day: 15 Month: 2 Year: 2013
Volume: 111 Issue: 4
First Page: 557 Last Page: 562
PubMed Id: 23219000
Publisher Id: AJC19347
|Noninvasive Cardiac Screening in Young Athletes With Ventricular Arrhythmias|
|Alexandros Klavdios Steriotisa∗||Email: email@example.com|
aDepartment of Cardiac, Thoracic and Vascular Sciences, University of Padua, Padua, Italy
bDepartment of Medical Diagnostic Sciences and Special Therapies, University of Padua, Padua, Italy
|∗Corresponding author: Tel: 39-0498218642; fax: 39-0498761764. firstname.lastname@example.org
Athlete's heart is generally regarded as a benign electroanatomic remodeling due to systematic training. Nevertheless, repolarization inhomogeneity of myocardium, a high prevalence of ventricular arrhythmias (VAs), and arrhythmogenic right ventricular (RV) cardiomyopathy–like phenotypes have been described in some athletes.1–5 Sports are associated with an increased risk for sudden death in athletes who are affected by cardiovascular conditions predisposing to life-threatening VAs during exercise.6 The incidence of sudden cardiac death in young competitive athletes has substantially decreased in the Veneto region of Italy thanks to the introduction of a preparticipation screening program that identifies subjects with previously unrecognized cardiovascular conditions.7 Rhythm and conduction abnormalities are the first cardiovascular causes of sports disqualification, and evaluation of VAs constitutes an important medical and legal issue.7 The aim of this study was to analyze using noninvasive cardiac examinations a series of young athletes discovered to have VAs.
One hundred forty-five young, nonelite, competitive athletes (mean age 17.3 ± 5.3 years, range 9 to 34; male/female ratio 106/39 = 2.7) were evaluated in our laboratory during a period of 3 years. All subjects were referred because of VAs detected during preparticipation screening, which also included exercise testing. The study protocol included family and personal histories, 12-lead electrocardiography (ECG), 2-dimensional echocardiography with Doppler analysis, 24-hour Holter monitoring, exercise testing, signal-averaged ECG, and in selected cases contrast-enhanced cardiac magnetic resonance imaging.
Electrocardiograms were evaluated using digital calipers at standard paper speed (25 mm/s). Electrocardiographic abnormalities were divided into 2 groups (common or training-related and uncommon or training-unrelated abnormalities) and interpreted considering the most recent recommendations.8,9 Signal-averaged ECG was performed using a MAC15 system (Marquette Inc., Milwaukee, Wisconsin). The following parameters for each of the 3 filters (25, 40, and 80 to 250 Hz) were evaluated: filtered QRS duration, high-frequency low-amplitude signal duration in the terminal portion of the filtered QRS interval with a voltage amplitude <40 μV (or <20 μV for the 80- to 250-Hz filter), and the root mean square of the voltage in the last 40 ms of the filtered QRS interval. Presence of late potentials was considered when ≥2 parameters were abnormal in 1 filter. The exercise test was performed on a bicycle or treadmill (with standard 12-lead placement) up to the submaximal heart rate, calculated from the formula 220 − age × 85%. ST-segment alterations and VAs were carefully evaluated. Holter monitoring was performed using 12-lead ECG (with standard lead placement). The number, morphologies, and coupling intervals of single and repetitive VAs were studied.
The echocardiographic study was performed with a 2.5- to 4-MHz transducer (model 5500, Philips Medical Systems, Andover, Massachusetts) and included M-mode, 2-dimensional, and Doppler examinations of the traditional views. Left ventricular (LV) end-diastolic diameter, parietal wall thickness, and left atrial diameter were calculated in the parasternal long-axis view using M-mode imaging. LV end-diastolic volume, end-systolic volume, and ejection fraction were calculated in the apical 4-chamber view (using Simpson's rule). RV end-diastolic area, end-systolic area, and fractional area change were calculated from the apical 4-chamber view, and the RV ejection fraction was also measured. The RV outflow tract was measured in the parasternal view and the short-axis view and the RV inflow tract in the 4-chamber view. The presence of LV and RV wall motion abnormalities was assessed.
Cardiac magnetic resonance imaging was performed using a 1.0-T clinical scanner (Harmony; Siemens Healthcare, Erlangen, Germany) using a phased-array cardiac receiver coil. After the intravenous administration of gadolinium, chelate inversion recovery prepared, breath-hold cine gradient-echo images were obtained. Cine, morphologic, and late gadolinium enhancement images acquired during the same imaging session were matched by slice position.
Data are expressed as mean ± SD for continuous variables and as frequencies with percentages for categorical variables. All continuous variables are expresses as mean ± SD.
The initial detection of premature ventricular complexes (PVCs) during the preparticipation program was due mostly to the exercise tests in 124 athletes (85%). In the remaining cases, PVCs were present on ECG (7 athletes [5%]) or detected on Holter monitoring (14 athletes [10%]).
Baseline electrocardiographic results were normal in 123 athletes (85%) (in 90 [62%] with the common abnormalities) and abnormal in 22 (15%) with the uncommon abnormalities. Mean values of rhythm (69 ± 11 beats/min), electrical QRS axis (73 ± 2°), PQ interval (147 ± 22 ms), QRS duration (93 ± 14 ms), corrected QT interval (414 ± 19 ms), and isolated QRS voltage criteria for LV hypertrophy (SV1 + RV5/V6 = 27 ± 8 mV) were normal. All athletes were in sinus rhythm. A mild right axis deviation of the QRS complex (+105°), present in 15 athletes (10.3%), was considered normal. The electrocardiographic common abnormalities were sinus bradycardia in 28 athletes (19.3%), first-degree atrioventricular block in 4 (2.8%), incomplete right bundle branch block (RBBB) in 37 (25.5%), isolated increases in QRS voltage in 17 (11.7%), and early repolarization in 50 (34.5%). The electrocardiographic uncommon abnormalities were left or right atrial enlargement in 4 athletes (2.8%), ventricular preexcitation in 1 (0.7%), complete RBBB in 3 (2.1%), signs of RV hypertrophy in 2 (1.4%), nondiagnostic Brugada-like ST-segment abnormalities in 4 (2.8%), ST-segment depression in 2 (1.4%), T-wave inversions in 8 (5.5%), and corrected QT interval prolongation in 3 (2.1%; 450 to 460 ms, male athletes). Normal T waves were present in 137 athletes (94.5%). Negative T waves in lead V1 were present in 99 athletes (68.2%) but were rare in other precordial leads: V1 to V2 (2.1%; age ≤14 years), V1 to V3 (1.4%), V1 to V4 (0.7%), lateral leads (0.7%), and ≥2 inferior leads (1.4%). Intraventricular conduction delays with QRS durations >120 ms were present in 4 athletes always, in conjunction with negative T waves in >1 precordial or inferior lead. VPCs were present on ECG in 33 athletes (22.7%).
Signal-averaged ECG was performed in 129 athletes (89%). Ten (6.9%) showed late potentials: 6 in 1 filter and 4 in 2 filters. The mean values of each filter were normal: filtered QRS duration 120.1 ± 11.4, 110.9 ± 14.8, and 97.1 ± 13 ms; high-frequency low-amplitude signal duration 17.8 ± 10.4, 28.8 ± 26.9, and 25.1 ± 11.3 ms; and root mean square of the voltage in the last 40 ms of the filtered QRS interval 105.6 ± 58.3, 50.5 ± 22.3, and 34.7 ± 23.6 mV.
Concerning echocardiographic alterations, typical findings of athlete's heart were detected in 38 subjects (26%; Table 1). In detail, LV end-diastolic diameter was increased (>56 mm) in 10% (mean 50 ± 5 mm), and ejection fractions were normal (mean 61 ± 4%) in all but 1. None had a parietal wall thickness >11 mm (septal wall 8 ± 1.2 mm, posterior wall 7.8 ± 1.2 mm). E/A ratios were normal in all (E = 82 ± 13 cm/s, A = 44 ± 12 cm/s) but 1 subject. Ea/Aa ratios, assessed in 68 athletes, were normal (Ea = 19.4 ± 4.8 cm/s, Aa = 7.9 ± 2.3 cm/s, Sa = 11.5 ± 2.9 cm/s). Left or right atrial enlargement was present in 10 athletes (6.9%). The presence of ≥1 LV false tendon was detected in 22%. RV enlargement (RV end-diastolic area >24 cm2) was present in 17% (mean 21 ± 4 cm2). The RV inflow tract was increased in size (>41 mm) in 19%. The RV outflow tract in the parasternal view was increased in size (≥19 mm/m2) in 3 athletes, and the RV outflow tract in the short-axis view was increased in size (≥21 mm/m2) in 2 athletes. RV systolic function was normal (fractional area change 45.5 ± 5.5%, ejection fraction 61.1 ± 4.6%) in all but 1 subject. Rich trabeculation (29%), globular-shaped apex (16%), and hyperechogenic moderator band (16%) were quite common. RV Ea/Aa ratios, assessed in 63 athletes, were normal in all (Ea = 14.9 ± 3.3 cm/s, Aa = 8.2 ± 2.9 cm/s, Sa = 13.1 ± 2.6 cm/s). Trivial regurgitations were detected in the tricuspid valve (75%), the mitral valve (63%), the pulmonary valve (41%), and the aortic valve (11%). One athlete had mild pulmonary hypertension. Mitral valve prolapse was found in 29 athletes (20%; 4 with mild regurgitation). Congenital heart disease was detected in 4 athletes (2.8%; a bicuspid aortic valve, a ventricular septal defect, a partial anomalous pulmonary venous return, and a persistent left superior vena cava). The suspicion of arrhythmogenic RV cardiomyopathy was raised in 3 subjects (2.1%), and isolated RV apical hypokinesia was found in another 2 (1.4%).
Holter monitoring showed a mean number of PVCs of 4,700 per day. The number of PVCs ranged from 0 to 720 per day in 49 athletes (33.8%), from 720 to 5,000 per day in 46 (31.7%), from 5,000 to 10,000 per day in 29 (20%), and from 10,000 to 20,000 per day in 17 (11.7%) and was >20,000 per day in 4 (2.8%). In 26 subjects (18%), PVCs numbered <20 per day and were judged nonsignificant. Only single PVCs were detected in 83 athletes (57%), and in the remaining athletes, repetitive forms were also detected (43%). Single PVCs had in 98% of subjects wide coupling intervals (>400 ms, mean 506 ± 104 ms). Among the 119 athletes with significant numbers of PVCs, in 105 (88%), PVCs were monomorphic. The most frequent PVC morphologies were left bundle branch block (LBBB) with inferior axis deviation (IAD) in 59 subjects (50%), RBBB with left axis deviation (LAD) in 21 (18%), LBBB with LAD in 18 (15%), RBBB with right axis deviation in 14 (12%), LBBB with normal axis in 14 (12%), and RBBB with IAD in 8 (7%) (Figure 1). IAD was considered between +75° and +105° and LAD ≤−30°. A total of 44 athletes (30%) showed ventricular couplets (monomorphic in 32, polymorphic in 12), with a mean coupling interval of 457 ± 181 (<400 ms in 11 [24%]); in 5 subjects, ventricular couplets were frequent (>100 per day), and in 1 case, they were frequent and short coupled. Asymptomatic, nonsustained ventricular tachycardia (VT) was present in 31 athletes (21%). Of these, 27 showed brief VT (3 to 10 beats): 17 presented triplets (mean rate 138 beats/min) and 10 presented runs from 4 to 10 beats (mean rate 170 beats/min). In 4 athletes, VT episodes of >10 beats were observed. Most athletes (n = 22 [71%]) showed single runs of VT during the day. The mean ventricular rate of all VTs was 130 beats/min (mean R-R interval 461 ms): 4 VTs (13%) with rates >210 beat/min, 9 (33%) with rates of 150 to 210 beats/min, 11 (35%) with rates of 100 to 150 beats/min, and 7 (22.5%) with rates <100 beats/min. Moreover, 4 athletes presented short runs of polymorphic VT. Overall, 13 VTs (9%) were judged potentially dangerous on the basis of electrocardiographic characteristics (short R-R interval, multiple or long episodes, polymorphism, exercise induction) or the presence of an organic substrate.10–12
Submaximal exercise tests were performed in 138 athletes (95%), and in 124 (90%), PVCs were recorded. Four basic patterns of PVC response to effort were found: (1) PVCs that disappeared during effort, reappearing during the recovery phase in 77 athletes (55.8%), (2) PVCs that appeared only during the recovery phase in 16 (11.6%), (3) PVCs that persisted during all exercise in 12 (8.7%), and (4) exercise-induced PVCs in 19 (13.8%) (3 with repetitive forms; in 15 cases, PVCs were totally absent at rest during Holter monitoring). Effort-induced PVCs showed LBBB morphology with IAD in 7 athletes (37%), RBBB with LAD in 6 (31%), LBBB with LAD in 3 (16%), LBBB with normal axis in 1 (0.7%), and RBBB with right axis deviation in 1 (0.7%). In 1 athlete, polymorphic PVCs were present. Supraventricular arrhythmias were present in 3.6%. No significant ST-T changes were recorded.
Thirty athletes underwent contrast-enhanced cardiac magnetic resonance imaging. Results were normal in 14; in 3, results confirmed a left superior vena cava, a partial anomalous pulmonary venous return, and a hypertrophic papillary muscle, and in 1 subject, mild septal late enhancement was present. Twelve athletes had ≥1 RV abnormal finding: 1 with moderate RV enlargement and 2 with mild diffuse hypokinesia. In 9 athletes, the presence of regional wall motion abnormalities was detected: apical hypokinesia in 3, RV systolic bulging in 3, akinetic regions in 2, and a dyskinetic region in 1. Among these subjects, 2 also showed late enhancement, and 3 showed regional fatty infiltrations. Only 1 subject presented with regional dysfunction plus a structural alteration (1 minor criterion for arrhythmogenic RV cardiomyopathy diagnosis).13
After clinical evaluation, 30% of athletes were judged to have potentially dangerous VAs on the basis of the presence of a morphologic substrate and/or the characteristics of VA pattern according to the recommendations for competitive sports, tailored to each athlete and type of sport10–12 (Figure 2). Borderline cases belonging to the “gray zone” of diagnosis between athlete's heart and arrhythmogenic RV cardiomyopathy were also judged potentially dangerous. Among these athletes, 10% (n = 14) were treated with antiarrhythmic drugs, in 1.4% (n = 2) ablation was indicated, and in 1 athlete surgical repair of the congenital defect was indicated. In the rest of the athletes, competitive sports were not recommended, and detraining was proposed (n = 26). Follow-up was feasible in 93 athletes (mean 28 months). A decrease of >70% in the number of PVCs compared to the first Holter monitoring was observed in 34 (37%), while in 31 (33%), VAs did not show significant changes, and in 28 (30%), PVCs increased. During follow-up, no athlete presented with a major cardiac event.
The research for a morphologic substrate in athletes with VAs is usually the primary goal, determining both the prognosis and recommendation for sports participation. Most VAs are not associated with underlying cardiac abnormalities, appearing to be an expression of “athlete's heart syndrome,” but in athletes with frequent and complex VAs, the prevalence of structural heart disease is higher.14 Concealed cardiomyopathies and primary electrical disorders are important causes of sudden death, and “benign” VAs could be the first expression of an early form of cardiomyopathy.15–19 Long-term follow-up studies in subjects with outflow tract VAs showed a benign prognosis.20,21 Nevertheless, potentially dangerous VAs in an apparently normal heart may create eligibility difficulties, evaluation becomes challenging, and careful, multiparametric analysis of all data should be performed.10–12,22,23
In this series, exercise testing performed during preparticipation screening was fundamental for PVC detection, because most athletes (85%) were referred for cardiologic screening because of PVC detection during the test. Sofi et al24 also found cardiac anomalies on exercise testing of athletes with normal findings on rest ECG. This is because an exercise test allows the monitoring of rhythm for a variable period of time. In our experience, 4 patterns of PVC response to exercise were found, with the most prevalent being the suppression of PVCs by exercise.
VAs were predominantly associated with normal results on ECG (85%; in 62% with common abnormalities). Early repolarization was the most common finding, and even if its significance in athletes with VAs is not yet completely clear, malignant early repolarization was not present.25,26 Abnormal results on ECG were infrequent (15%), and only 5% presented frankly pathologic electrocardiographic alterations. It is noteworthy that negative T waves beyond lead V2 are usually considered a marker of disease, and this was confirmed by our study, as all 3 athletes with negative T waves from leads V1 to V3 or V4 (2.1%) were ultimately diagnosed with structural heart disease (partial anomalous pulmonary venous return, arrhythmogenic RV cardiomyopathy, and accessory pathway).27 Diagnostic channelopathic electrocardiographic features were not present, and borderline findings on ECG were rare (5%) and judged as electrocardiographic variants.9 The appearance of PVCs on 23% of electrocardiograms can be considered a marker of more frequent ectopy at all times, as all subjects showed frequent PVCs on Holter monitoring. The presence of late potentials was quite rare, and subjects with late potentials did not show the presence of significant VAs or echocardiographic alteration. Nonetheless, it may be useful for risk stratification, and the absence of late potentials is still an important finding.28
Analysis of VAs on Holter monitoring showed that PVCs were often frequent, monomorphic, single, and/or in couplets, with wide coupling intervals (Figure 1). Couplets were present in 30% of athletes and were usually rare and monomorphic, with wide coupling intervals. VTs were present in 21%, all nonsustained, usually as single and brief runs during the day; in only 2.8% of cases were VTs fast. VAs were more frequently idiopathic (n = 119 [82%]) and in 12% of subjects (n = 20) were judged as a severe pattern (Figure 2).
The most frequent pathologic echocardiographic finding was mitral valve prolapse (20%; Table 1). Importantly, most subjects with mitral valve prolapse had normal results on ECG, and in 38%, prolapse was associated with VAs of RBBB morphology at rest or during effort, which could be a limiting factor for sports eligibility in some athletes. Regarding the presence of kinetic abnormalities, 6 athletes showed RV regional kinetic abnormalities (4.1%). Of these, 3 athletes were suspected to have a possible form of arrhythmogenic RV cardiomyopathy (with a definite diagnosis in only 1). One athlete showed a partial anomalous venous pulmonary return, and 2 had isolated RV apical hypokinesia. Additionally, 2 congenital heart diseases (bicuspid aortic valve and ventricular septal defect) were identified in the presence of normal results on ECG.
Regarding the results of cardiac magnetic resonance imaging, the significance of localized abnormalities in terms of diagnosis and prognosis is not currently known. In patients with RV arrhythmias, RV focal fatty replacement may be present, and although a recent study demonstrated that the presence of RV abnormalities is associated with worse outcomes, more follow-up studies are needed to clarify the nature of RV abnormalities in athletes.19,20,29 From our cohort, in 9 subjects, localized RV morphofunctional abnormalities were detected, but only 1 fulfilled the magnetic resonance criteria for arrhythmogenic RV cardiomyopathy.13 In the remaining cases, diagnosis and the decision for sports eligibility remain challenging, and careful clinical management and close follow-up are mandatory if invasive investigations are not undertaken.1,4,18,19,28
The authors have no conflicts of interest to disclose.
d31e160This study was supported by TELETHON Rome GGP09293; Fondazione CARIPARO, Padua, Italy; and the Registry of Cardiocerebrovascular Pathology, Veneto Region, Venice, Italy.
d31e175See page 561 for disclosure information.
|1.||Maron B.J.,Pelliccia A.. The heart of trained athletes: cardiac remodeling and the risk of sports, including sudden deathCirculation114Year: 20061633164417030703|
|2.||Varró A.,Baczkó I.. Possible mechanisms of sudden death in top athletes: a basic cardiac electrophysiological point of viewPflugers Arch460Year: 2010314020186549|
|3.||Palatini P.,Maraglino G.,Sperti G.,Calzavara A.,Libardoni M.,Pessina A.C.,Dal Palù C.. Prevalence and possible mechanisms of ventricular arrhythmias in athletesAm Heart J110Year: 19855605672412427|
|4.||Heidbüchel H.,Hoogsteen J.,Fagard R.,Vanhees L.,Ector H.,Willems R.,Van Lierde J.. High prevalence of right ventricular involvement in endurance athletes with ventricular arrhythmias. Role of an electrophysiologic study in risk stratificationEur Heart J24Year: 20031473148012919770|
|5.||La Gerche A.,Robberecht C.,Kuiperi C.,Nuyens D.,Willems R.,de Ravel T.,Matthijs G.,Heidbüchel H.. Lower than expected desmosomal gene mutation prevalence in endurance athletes with complex ventricular arrhythmias of right ventricular originHeart96Year: 20101268127420525856|
|6.||Corrado D.,Basso C.,Rizzoli G.,Schiavon M.,Thiene G.. Does sports activity enhance the risk of sudden death in adolescents and young adults?J Am Coll Cardiol42Year: 20031959196314662259|
|7.||Corrado D.,Basso C.,Pavei A.,Michieli P.,Schiavon M.,Thiene G.. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening programJAMA296Year: 20061593160117018804|
|8.||Corrado D.,Pelliccia A.,Heidbuchel H.,Sharma S.,Link M.,Basso C.,Biffi A.,Buja G.,Delise P.,Gussac I.,Anastasakis A.,Borjesson M.,Bjørnstad H.H.,Carrè F.,Deligiannis A.,Dugmore D.,Fagard R.,Hoogsteen J.,Mellwig K.P.,Panhuyzen-Goedkoop N.,Solberg E.,Vanhees L.,Drezner J.,Estes N.A. III,Iliceto S.,Maron B.J.,Peidro R.,Schwartz P.J.,Stein R.,Thiene G.,Zeppilli P.,McKenna W.J.,Section of Sports Cardiology, European Association of Cardiovascular Prevention and Rehabilitation,Working Group of Myocardial and Pericardial Disease, European Society of CardiologyRecommendations for interpretation of 12-lead electrocardiogram in the athleteEur Heart J31Year: 201024325919933514|
|9.||Uberoi A.,Stein R.,Perez M.V.,Freeman J.,Wheeler M.,Dewey F.,Peidro R.,Hadley D.,Drezner J.,Sharma S.,Pelliccia A.,Corrado D.,Niebauer J.,Estes N.A. III,Ashley E.,Froelicher V.. Interpretation of the electrocardiogram of young athletesCirculation124Year: 201174675721824936|
|10.||Zipes D.P.,Ackerman M.J.,Estes N.A. III,Grant A.O.,Myerburg R.J.,Van Hare G.. Task Force 7: arrhythmiasJ Am Coll Cardiol45Year: 20051354136315837287|
|11.||Pelliccia A.,Fagard R.,Bjørnstad H.H.,Anastassakis A.,Arbustini E.,Assanelli D.,Assanelli D.,Biffi A.,Borjesson M.,Carrè F.,Corrado D.,Delise P.,Dorwarth U.,Hirth A.,Heidbuchel H.,Hoffmann E.,Mellwig K.P.,Panhuyzen-Goedkoop N.,Pisani A.,Solberg E.E.,van-Buuren F.,Vanhees L.,Blomstrom-Lundqvist C.,Deligiannis A.,Dugmore D.,Glikson M.,Hoff P.I.,Hoffmann A.,Hoffmann E.,Horstkotte D.,Nordrehaug J.E.,Oudhof J.,McKenna W.J.,Penco M.,Priori S.,Reybrouck T.,Senden J.,Spataro A.,Thiene G.,Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise PhysiologyWorking Group of Myocardial and Pericardial Diseases of the European Society of CardiologyRecommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of CardiologyEur Heart J26Year: 20051422144515923204|
|12.||Heidbüchel H.,Corrado D.,Biffi A.,Hoffmann E.,Panhuyzen-Goedkoop N.,Hoogsteen J.,Delise P.,Hoff P.I.,Pelliccia A.,Study Group on Sports Cardiology of the European Association for Cardiovascular Prevention and RehabilitationRecommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions. Part II: ventricular arrhythmias, channelopathies and implantable defibrillatorsEur J Cardiovasc Prev Rehabil13Year: 200667668617001205|
|13.||Marcus F.I.,McKenna W.J.,Sherrill D.,Basso C.,Bauce B.,Bluemke D.A.,Calkins H.,Corrado D.,Cox M.G.,Daubert J.P.,Fontaine G.,Gear K.,Hauer R.,Nava A.,Picard M.H.,Protonotarios N.,Saffitz J.E.,Sanborn D.M.,Steinberg J.S.,Tandri H.,Thiene G.,Towbin J.A.,Tsatsopoulou A.,Wichter T.,Zareba W.. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteriaCirculation121Year: 20101533154120172911|
|14.||Biffi A.,Pelliccia A.,Verdile L.,Fernando F.,Spataro A.,Caselli S.,Santini M.,Maron B.J.. Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletesJ Am Coll Cardiol40Year: 200244645212142109|
|15.||Basso C.,Corrado D.,Thiene G.. Cardiovascular causes of sudden death in young individuals including athletesCardiol Rev7Year: 199912713510423663|
|16.||De Noronha S.V.,Sharma S.,Papadakis M.,Desai S.,Whyte G.,Shepphard M.N.. Aetiology of sudden cardiac death in athletes in the United Kingdom: a pathological studyHeart95Year: 20091409141419443476|
|17.||Biffi A.. Idiopathic ventricular arrhythmias in athletes: their causes and when to grant sports eligibilityJ Cardiovasc Med (Hagerstown)7Year: 200627928116645402|
|18.||Corrado D.,Basso C.,Leoni L.,Tokajuk B.,Turrini P.,Bauce B.,Frigo G.,Tarantini G.,Napodano M.,Turrini P.,Ramondo A.,Daliento L.,Nava A.,Buja G.,Iliceto S.,Thiene G.. Three-dimensional electroanatomical voltage mapping and histologic evaluation of myocardial substrate in right ventricular outflow tract tachycardiaJ Am Coll Cardiol51Year: 200873173918279737|
|19.||Dello Russo A.,Pieroni M.,Santangeli P.,Bartoletti S.,Casella M.,Pelargonio G.,Smaldone C.,Bianco M.,Di Biase L.,Bellocci F.,Zeppilli P.,Fiorentini C.,Natale A.,Tondo C.. Concealed cardiomyopathies in competitive athletes with ventricular arrhythmias and an apparently normal heart: role of cardiac electroanatomic mapping and biopsyHeart Rhythm8Year: 20111915192221782775|
|20.||Gaita F.,Giustetto C.,Di Donna P.,Richiardi E.,Libero L.,Brusin M.C.,Molinari G.,Trevi G.. Long-term follow-up of right ventricular monomorphic extrasystolesJ Am Coll Cardiol38Year: 200136437011499725|
|21.||Niwano S.,Wakisaka Y.,Niwano H.,Fukaya H.,Kurokawa S.,Kiryu M.,Izumi T.. Prognostic significance of frequent premature ventricular contractions originating from the ventricular outflow tract in patients with normal left ventricular functionHeart95Year: 20091230123719429571|
|22.||Viskin S.,Antzelevitch C.. The cardiologists' worst nightmare sudden death from “benign” ventricular arrhythmiasJ Am Coll Cardiol46Year: 20051295129716198846|
|23.||Noda T.,Shimizu W.,Taguchi A.,Aiba T.,Satomi K.,Suyama K.,Kurita T.,Aihara N.,Kamakura S.. Malignant entity of idiopathic ventricular fibrillation and polymorphic ventricular tachycardia initiated by premature extrasystoles originating from the right ventricular outflow tractJ Am Coll Cardiol46Year: 20051288129416198845|
|24.||Sofi F.,Capalbo A.,Pucci N.,Giuliattini J.,Condino F.,Alessandri F.,Abbate R.,Gensini G.F.,Califano S.. Cardiovascular evaluation, including resting and exercise electrocardiography, before participation in competitive sports: cross sectional studyBMJ337Year: 2008a34618599474|
|25.||Noseworthy P.A.,Weiner R.,Kim J.,Keelara V.,Wang F.,Berkstresser B.,Wood M.J.,Wang T.J.,Picard M.H.,Hutter A.M. Jr.,Newton-Cheh C.,Baggish A.L.. Early repolarization pattern in competitive athletes: clinical correlates and the effects of exercise trainingCirc Arrhythm Electrophysiol4Year: 201143244021543642|
|26.||Antzelevitch C.. Genetic, molecular and cellular mechanisms underlying the J wave syndromesCirc J76Year: 20121054106522498570|
|27.||Marcus F.I.. Prevalence of T-wave inversion beyond V1 in young normal individuals and usefulness for the diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasiaAm J Cardiol95Year: 20051070107115842973|
|28.||Zipes D.P.,Camm A.J.,Borggrefe M.,Buxton A.E.,Chaitman B.,Fromer M.,Gregoratos G.,Klein G.,Moss A.J.,Myerburg R.J.,Priori S.G.,Quinones M.A.,Roden D.M.,Silka M.J.,Tracy C.,Smith S.C. Jr.,Jacobs A.K.,Adams C.D.,Antman E.M.,Anderson J.L.,Hunt S.A.,Halperin J.L.,Nishimura R.,Ornato J.P.,Page R.L.,Riegel B.,Blanc J.J.,Budaj A.,Dean V.,Deckers J.W.,Despres C.,Dickstein K.,Lekakis J.,McGregor K.,Metra M.,Morais J.,Osterspey A.,Tamargo J.L.,Zamorano J.L.,American College of Cardiology/American Heart Association Task Force,European Society of Cardiology Committee for Practice Guidelines,European Heart Rhythm Association,Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm SocietyCirculation114Year: 2006e385e48416935995|
|29.||Aquaro G.D.,Pingitore A.,Strata E.,Di Bella G.,Molinaro S.,Lombardi M.. Cardiac magnetic resonance predicts outcome in patients with premature ventricular complexes of left bundle branch block morphologyJ Am Coll Cardiol56Year: 20101235124320883930|
Previous Document: Low-dose Anticoagulation for Secondary Prevention in Acute Coronary Syndrome.
Next Document: Parametrisation of the free energy of ATP binding to wild-type and mutant Kir6.2 potassium channels.